Taiko Pharmaceutical Co. Ltd. | Ownership
Companies that own Taiko Pharmaceutical Co. Ltd.
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
195,400
1.37%
195,400
0.01%
01/22/2018
Nomura Asset Management Co., Ltd.
182,100
1.28%
1,000
0%
07/31/2018
Daiwa Asset Management Co. Ltd.
87,200
0.61%
-200
0%
07/31/2018
Nikko Asset Management Co., Ltd.
78,699
0.55%
100
0%
08/20/2018
FIL Investments (Japan) Ltd.
61,399
0.43%
61,399
0.01%
11/30/2017
Dimensional Fund Advisors LP
40,300
0.28%
-55,600
0%
04/30/2018
MU Investments Co., Ltd.
24,600
0.17%
24,600
0.14%
01/22/2018
Analytic Investors LLC
23,500
0.17%
-4,900
0%
08/31/2018
SSgA Funds Management, Inc.
13,300
0.09%
0
0%
09/06/2018
Asset Management One Co., Ltd.
9,599
0.07%
299
0%
04/20/2018
| Address |
ORIX Honmachi Building, 16F
Osaka Osaka 550
Japan
|
|
Employees
|
- |
| Website |
http://www.seirogan.co.jp |
| Updated |
07/08/2019 |
| Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs, and sanitation control products. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the manufacture, procurement and sale of non-prescription (OTC) drugs in Japan and overseas. |
